Product Name: TEG5000 Analyzer (07-022, 07-033) with TEG Analytical Software (07-030, 07-031) and...

FDA Device Recall #Z-1298-2022 — Class II — April 19, 2022

Recall Summary

Recall Number Z-1298-2022
Classification Class II — Moderate risk
Date Initiated April 19, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Haemonetics Corporation
Location Boston, MA
Product Type Devices
Quantity 111

Product Description

Product Name: TEG5000 Analyzer (07-022, 07-033) with TEG Analytical Software (07-030, 07-031) and TEG Platelet Mapping Assay - PlateletMapping ADP & AA (07-014), PlateletMapping ADP (07-015), PlateletMapping AA (07-016). Issue occurs when Platelet Mapping Assay results from a TEG 5000 analyzer are viewed using TEG Manager Software (versions 1.1-4.3.1)

Reason for Recall

When the TEG 5000 Analyzer including TEG Analytical Software is used with PlateletMapping (ADP or AA) Assays and TEG Mangement Software, incorrect values of the PlateletMapping ADP or AA % Inhibition and % Aggretagion may be displayed on TEG Manager for the affected assays.

Distribution Pattern

US Nationwide.

Lot / Code Information

This correction is applicable when TEG 5000 PlateletMapping (Item # 07-014, 07-015, 07-016) is performed on a TEG 5000 analyzer (Item # 07-022, 07-033) that is connected to TEG Manager Software which includes viewing of TEG 5000 results. Code Info: UDI-DI: (01)30812747018184 Software Version: TEGM 1.1 and later, TAS v4.2.3

Other Recalls from Haemonetics Corporation

Recall # Classification Product Date
Z-1310-2022 Class II TEG 5000 Functional Fibrinogen Reagent, Item No... Apr 26, 2022
Z-1617-2020 Class II TEG Manager software versions used in conjuncti... Feb 19, 2020
Z-0897-2020 Class II JAPAN LOW VOL(125ML) CS5 SET,LN 261J - Product ... Oct 21, 2019
Z-0890-2020 Class II CS5/5+ Fastpacks, 225 mL, 20¿ Res Autotransfusi... Oct 21, 2019
Z-0900-2020 Class II JAPAN DISP SET, 261J, 205J, HAR - Product Usage... Oct 21, 2019

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.